However, evidence of successful use of these agents for aphthous ulcers is ... a significant difference between treatment and placebo groups in days with ulcers or ulcer pain.

The clinical features, etiology, and treatment of recurrent aphthous ulcers (RAU) are discussed. Aphthous ulcers are among the most common oral lesions in the general population, with a frequency ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Additionally, despite the biologic activity observed in aphthous ulcers induced by chemotherapy and radiation, there can be no assurance as to the timing or success of the clinical trials of SGX945 ...

Given the promising biologic activity observed with aphthous ulcers in oral mucositis ... There is no cure for Behçet's Disease, rather treatments are prescribed to manage symptoms.

there can be no assurance as to the timing or success of the clinical trials of SGX302 for the treatment of psoriasis. Additionally, despite the biologic activity observed in aphthous ulcers ...

Treatments may include both maintenance therapies and those ... authorization to start patient enrollment into our SGX945 Phase 2a pilot trial in aphthous ulcers of Behçet’s Disease,” stated ...

Canker sores (also known as aphthous ulcers) occur in both adults and children with undiagnosed ... National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for Celiac Disease: ...